Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M83.7Revenue (TTM) $M2.5Net Margin (%)-1,623.1Altman Z-Score-35.1
Enterprise Value $M90.3EPS (TTM) $-3.0Operating Margin %-1,570.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-1,623.1Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-31.8Quick Ratio2.4Cash flow > EarningsY
Price/Sales21.95-y EBITDA Growth Rate %-6.9Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-115.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-289.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSFirst Eagle Investment 2016-06-30 Buy $2.7 - $3.6
($3.17)
$ 4.0126%New holding250,000
SNSSFirst Eagle Investment 2015-06-30 Sold Out $12.42 - $18.06
($15.18)
$ 4.01-74%Sold Out0
SNSSFirst Eagle Investment 2015-03-31 Reduce-0.01%$12.6 - $16.98
($14.41)
$ 4.01-72%Reduce -58.43%97,996
SNSSFirst Eagle Investment 2014-12-31 Buy 0.01%$6.3 - $39.84
($12.45)
$ 4.01-68%New holding235,713
SNSSFirst Eagle Investment 2014-09-30 Sold Out -0.0032%$33.32 - $49.38
($41.36)
$ 4.01-90%Sold Out0
SNSSFirst Eagle Investment 2014-06-30 Reduce$28.02 - $42.66
($33.25)
$ 4.01-88%Reduce -8.91%33,333
SNSSFirst Eagle Investment 2014-03-31 Reduce$24.96 - $43.8
($33.22)
$ 4.01-88%Reduce -8.50%36,593
SNSSFirst Eagle Investment 2013-12-31 Add$27.54 - $31.62
($29.53)
$ 4.01-86%Add 19.98%39,993
SNSSFirst Eagle Investment 2013-09-30 Buy $27.3 - $36.3
($30.53)
$ 4.01-87%New holding33,333
SNSSFirst Eagle Investment 2013-03-31 Sold Out -0.0052%$24 - $38.94
($31.34)
$ 4.01-87%Sold Out0
SNSSFirst Eagle Investment 2012-09-30 Reduce$15.84 - $34.56
($21.43)
$ 4.01-81%Reduce -30.24%58,333
SNSSFirst Eagle Investment 2012-06-30 Buy 0.01%$15.12 - $18.66
($16.62)
$ 4.01-76%New holding83,621
SNSSFirst Eagle Investment 2012-03-31 Sold Out -0.0026%$7.32 - $17.22
($10.84)
$ 4.01-63%Sold Out0
SNSSFirst Eagle Investment 2011-12-31 Buy $6.48 - $8.7
($7.63)
$ 4.01-47%New holding83,621
SNSSFirst Eagle Investment 2009-12-31 Sold Out $10.8 - $75.24
($22.53)
$ 4.01-82%Sold Out0
SNSSFirst Eagle Investment 2009-06-30 Reduce$5.94 - $20.7
($11.71)
$ 4.01-66%Reduce -90.60%2,778
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.873.62view
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.873.62view
Parker Geoffrey M.Director 2016-05-26Buy1,583$2.8242.2view
Parker Geoffrey M.Director 2016-05-25Buy8,751$2.8242.2view
Misfeldt DaytonDirector 2015-12-21Buy291,667$5.04-20.44view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy4,167$6.06-33.83view
Ketchum Steven BDirector 2015-07-24Sell1,060$20.76-80.68view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell1,060$20.76-80.68view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell2,119$20.76-80.68view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell105,951$20.76-80.68view

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Roundys Among Largest Insiders' Buys of the Week Dec 31 2015 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Jul 28 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
Minerva Presents Additional Data from Schizophrenia Drug Jan 23 2017
7:01 am Sunesis Pharma announces its IND application with the FDA is now active; recently received... Jan 23 2017
Sunesis Pharmaceuticals Announces Clinical and Regulatory Updates to SNS-062 and Vosaroxin Programs Jan 23 2017
Aduro (ADRO) Inks License Agreement with Stanford University Jan 20 2017
Synergy (SGYP) Trulance Wins FDA Approval for Constipation Jan 20 2017
How MEI Pharma Inc (MEIP) Stacks Up Against Its Peers Dec 15 2016
Sunesis Pharmaceuticals Announces Presentation of Updated Results from the VALOR Trial Examining... Dec 05 2016
Sunesis Pharmaceuticals Announces Presentation of Results from Completed Phase 1A Healthy Volunteer... Dec 05 2016
SUNESIS PHARMACEUTICALS INC Financials Nov 10 2016
Sunesis Pharmaceuticals Announces Presentations at ASH Annual Meeting Nov 03 2016
Sunesis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent Highlights Nov 03 2016
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 03 2016
Sunesis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent Highlights Nov 03 2016
Sunesis Pharmaceuticals Inc (SNSS): Cormorant Asset Management Reports New 5.14% Stake Nov 02 2016
Sunesis to Host Conference Call on November 3rd to Discuss Third Quarter 2016 Financial Results and... Oct 27 2016
Sunesis to Host Conference Call on November 3rd to Discuss Third Quarter 2016 Financial Results and... Oct 27 2016
Sunesis Announces Closing of Public Offerings and Full Exercise of Underwriters’ Option to... Oct 24 2016
Sunesis Announces Closing of Public Offerings and Full Exercise of Underwriters’ Option to... Oct 24 2016
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material... Oct 19 2016
Sunesis Announces Pricing of $25 Million Offering of Securities Oct 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)